Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Eur J Cancer. 2021 Mar 23;148:287–296. doi: 10.1016/j.ejca.2021.01.053

Figure 3.

Figure 3.

3A. DISEASE-FREE SURVIVAL (DFS) ANALYSIS; 3B. OVERALL SURVIVAL (OS) ANALYSIS Kaplan-Meier curves. *p-values are descriptive, not inferential. DFS indicates disease-free survival; Lap, lapatinib; OS, overall survival; and Tras, trastuzumab.